385114002: Prolonged-release transdermal patch (dose form)

SNOMED CT Concept\Qualifier value\Pharmaceutical dose form (dose form)\Transdermal dose form (dose form)\Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prolonged-release transdermal patch (dose form)	Is a	kutan OG/ELLER transdermal doseringsform	false	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Is a	medicinsk plaster	false	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility.	An intended site for a dose form that is for administration to the skin in order to obtain an effect after absorption through the skin barrier.	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Is a	Transdermal dose form (dose form)	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form administration method (attribute)	A method of administration of a dose form by placing or spreading on a body surface.	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form release characteristic (attribute)	A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods.	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has basic dose form (attribute)	A solid single-dose form that is flexible and intended to be applied to a body surface to release the active substance(s) over a period of time.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Capsaicin 179mg/hour transdermal patch	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 20 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 5microgram/hour transdermal patch	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
nicotinplaster 11 mg/24 timer	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
nicotinplaster 22 mg/dag	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,025 mg/dag plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,0375 mg/dag plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,05 mg/dag plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,075 mg/dag plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,1 mg/dag plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
scopolamin 0,5 mg/24-timer plaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,05 mg + norethindronacetat 0,14 mg/dag depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 0,05 mg + norethindronacetat 0,25 mg/dag depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
estradiol 14 µg/dag depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
ethynylestradiol 0,02 mg + norelgestromin 0,15 mg pr. dag depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
selegilin 6 mg/24 timer depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
selegilin 9 mg/24 timer depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
selegilin 12 mg/24 timer depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
rivastigmin 4,6 mg/24 timer depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
rivastigmin 9,5 mg/24 timer depotplaster	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.06mg/day transdermal patch	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 3.125 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.042 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.563 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Testosterone 104.167 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Testosterone 208.333 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 625 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.56 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 583 nanogram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 500 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 375 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 458 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 5 microgram/hour prolonged-release transdermal patch	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 1.563 milligram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some

Reference Sets

GB English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3634738017	Prolonged-release transdermal patch (dose form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3634739013	Prolonged-release transdermal patch	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3861641000005117	depotplaster	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)
4841841000005114	depotplastre	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)